Malignant Hematology

Dr. C. Tom Kouroukis

The Division of Malignant Hematology is responsible for the evaluation, treatment and extensive care of patients with a variety of blood-related diseases. There are four full-time members of the division who hold faculty appointments in the Department of Oncology and three associate members from the Division of Hematology and Thromboembolism who hold full-time faculty appointments in the Department of Medicine.

From a research perspective, members are active participants in the National Cancer Institute of Canada Clinical Trials Group, the PHL Consortium, and participate in a variety of phase I, II and III national and international studies. Members have been involved with health services and outcomes research and are closely associated with the Program In Evidence Based Care for Cancer Care Ontario which is instrumental in developing clinical practice guidelines.